Economy & Economic Development  January 7, 2020

AveXis marks opening of Longmont plant

LONGMONT — AveXis Inc. marked the completion of retrofitting its 692,000-square-foot drug-manufacturing campus in Longmont Tuesday morning, capping off a year of regulatory victories and intense criticism within the health-care industry.

AveXis’ drug production plant in Longmont. Courtesy Binswanger.

Before an assembled crowd of employees and public officials, AveXis president Dave Lennon said the company views the Longmont plant as the future for producing its flagship drug Zolgensma and gene therapies for other conditions in the company’s pipeline.

“Longmont will be on the leading edge of…

Related Posts

Sign up for BizWest Daily Alerts
Closing in 8 seconds...